research use only
#retatrutide 2026-01-18
Sunday37 messages9 participantstimes are UTC
Highlights from this day
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom
[edited]mine went up too
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
anyone gone above 10 and what changed
no long term data
TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule
triple agonist yeah
lost 8kg over 21 months at doses well under what the trials used
ok so stopped for 9 months and restarted at half my old dose, the ramp was easier second time
nobody should read my log as a plan, im recording what i did and thats all it is
is the GI worse than tirzepatide or about the same
the half life supports weekly dosing and thats what ive done from the start
👍15
Medutest came back 99 on one lot and 98.6 on the next from the same FGP, both fine
how do people square the research use only framing with logging their own use
is the glucagon arm what people mean by the energy expenditure thing
settled by month three
the honest position is this has less human evidence behind it than anything else discussed here
💀1
held mine ages
no idea whether the heart rate settles for everyone, mine did and one log isnt data
GI was about the same as tirzepatide for me, the difference was how fast it arrived
my resting rate went up 8 bpm in the first month and came back most of the way by month 12
sat at 0.5 for 7 months rather than climbing and it kept working, so i never went up
anyone compared their PeptideMeter purity across two different QST lots
cant feel it honestly
Archive lookup: tyne_tracks first appears in this channel on 2025-10-30.
is the phase 2 dosing anywhere near what people here run
i said 8 months ago that my heart rate had settled and it has stayed settled since
glucagon is the new bit
🤝9
whats the half life like, is it weekly the same way
why does everyone insist on smaller steps here than on the other two
people insist on small steps because the side effects arrive faster than on the other two
update on the earlier thing research use only is on every vial and i treat it as exactly that, nobody here is prescribing, thats one data point
anyone stayed at 0.25 for months rather than climbing
sorry to jump in triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
back after 26 months, has anything actually been published since
i log resting heart rate every morning because of this and its the one number i actually watch, we shall see